Related Experiment Video

Updated: Jul 4, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

EMT and MET in carcinoma--clinical observations, regulatory pathways and new models

Erik W Thompson1, Elizabeth D Williams

  • 1Department of Surgery, VBCRC Invasion and Metastasis Unit, St. Vincent's Hospital, St. Vincent's Institute, The University of Melbourne, Fitzroy, VIC, Australia. rik@medstv.unimelb.edu.au

Clinical & Experimental Metastasis
|June 21, 2008
PubMed

Insights

Epithelial-mesenchymal transition (EMT) and its reversal, mesenchymal-epithelial transition (MET), are crucial in carcinoma. Understanding these processes aids in developing new therapeutic models.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) are dynamic cellular processes.
  • These transitions are implicated in carcinoma progression, metastasis, and therapeutic resistance.

Discussion:

  • Clinical observations link EMT and MET to carcinoma invasiveness and patient outcomes.
  • Regulatory pathways governing EMT and MET involve complex signaling networks.

Key Insights:

  • New models are emerging to better understand and predict EMT and MET dynamics in cancer.
  • Targeting EMT/MET pathways presents a promising strategy for novel cancer therapies.

Outlook:

  • Further research into EMT and MET regulatory networks will refine therapeutic strategies.
  • Developing predictive biomarkers for EMT/MET status is essential for personalized oncology.

More Related Videos

A Preclinical Murine Model of Hepatic Metastases06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...